Results summary | View all lists in L2L MDB | View all genes in L01AD.profile.u50 |
Up-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 34.12-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
221577_X_AT | GDF15 | C | S | ![]() |
![]() |
growth differentiation factor 15 | |||||||
202922_AT | GCLC | G | X | E | R | ![]() |
![]() |
glutamate-cysteine ligase, catalytic subunit | |||||
203925_AT | GCLM | X | E | ![]() |
![]() |
glutamate-cysteine ligase, modifier subunit | |||||||
202923_S_AT | GCLC | G | X | E | R | ![]() |
![]() |
glutamate-cysteine ligase, catalytic subunit | |||||
209160_AT | AKR1C3 | E | ![]() |
![]() |
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | ||||||||
219475_AT | OSGIN1 | D | ![]() |
![]() |
oxidative stress induced growth inhibitor 1 | ||||||||
201266_AT | TXNRD1 | E | S | ![]() |
![]() |
thioredoxin reductase 1 |